Cetuximab
Summary
Hazard - P - B - T - Risk Exempt
EPAR – scientific discussion
Scientific discussion for Erbitux (cetuximab) 30/10/2006.
Risk
"No environmental risk assessment was submitted. Considering the intended use, the metabolic pathways of antibodies in general and the ubiquitous presence of decomposing organisms, no environmental concerns are expected with use of cetuximab."
Fass environmental information
Fass environmental information for Erbitux from Merck (downloaded 2019-07-09).
Risk
The use of amino acids, proteins and peptides is not considered to have any environmental impact.
According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00) vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.
Author: Health and Medical Care Administration, Region Stockholm